Sort   by:  
 Page size 
UnknownPhase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Not available
S-EPMC5455685 | biostudies-literature
UnknownFibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction.
Not available
S-EPMC7433891 | biostudies-literature
UnknownCartilage-like composition of keloid scar extracellular matrix suggests fibroblast mis-differentiation in disease.
Not available
S-EPMC7852214 | biostudies-literature
UnknownPhosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
Not available
S-EPMC1194899 | biostudies-literature
UnknownGermline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.
Not available
S-EPMC9098909 | biostudies-literature
Genomicsb1db14cd-994c-4440-908e-9e7aab02d88f - samples
This dataset contains one vcf file with variants from whole exome sequencing of 24 paediatric AML samples at diagnosis.
EGAD00001008783 | EGA
GenomicsGermline variant analysis in childhood AML
Analysis of rare germline variants in childhood AML in a large panel of cancer predisposition genes (n=216) compiled from literature review, and including genes involved in familial hematological malignancies (HM) and bone marrow failure (BMF) syndromes. The prevalence of extremely rare variants in ...
EGAS00001006276 | EGA
GenomicsUQ Data Access Commitee
Data Access Committee EGAC00001002686
EGAC00001002686 | EGA
GenomicsGenomic Sequencing of Medulloblastoma

Medulloblastomas are the most common malignant brain tumors in children. Identifying and understanding the genetic events that drive these tumors is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. Recently, our group and others described distinct ...

phs000504.v1.p1 | EGA
TranscriptomicsValidation of a genomic classifier that predicts metastasis following radical prostatectomy in at risk patient population
Purpose: Patients with locally advanced prostate cancer after radical prostatectomy are candidates for secondary therapy. However, this higher risk population is heterogeneous. Many cases do not metastasize even when conservatively managed. Given the limited specificity of pathological features to p...
ORGANISM(S): Homo sapiens 
2014-11-13 | E-GEOD-62116 | biostudies-arrayexpress
Sort   by:  
 Page size